Variant report
Variant | nsv468865 |
---|---|
Chromosome Location | chr11:106485489-106527673 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs556084418 | chr11:106489948-106489949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs576714521 | chr11:106490014-106490015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115826558 | chr11:106490024-106490025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181462962 | chr11:106490044-106490045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529804028 | chr11:106490046-106490047 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547965488 | chr11:106490063-106490064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs376542054 | chr11:106490066-106490067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569844361 | chr11:106490096-106490097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs185948836 | chr11:106490120-106490121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552584257 | chr11:106490144-106490145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191839998 | chr11:106490303-106490304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141700427 | chr11:106490317-106490318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182424058 | chr11:106490369-106490370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527564123 | chr11:106490479-106490480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117140550 | chr11:106490492-106490493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185758059 | chr11:106490494-106490495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs557585053 | chr11:106490518-106490519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576245381 | chr11:106490542-106490543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs541649675 | chr11:106490568-106490569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567450777 | chr11:106490624-106490625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143760867 | chr11:106490629-106490630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558524450 | chr11:106490658-106490659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576732880 | chr11:106490701-106490702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541332741 | chr11:106490706-106490707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373940346 | chr11:106490731-106490732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs75773050 | chr11:106490741-106490742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561454454 | chr11:106490777-106490778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs61903125 | chr11:106490782-106490783 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs537820875 | chr11:106490820-106490821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs1791586 | chr11:106490871-106490872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112165204 | chr11:106490899-106490900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116571108 | chr11:106490900-106490901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532443129 | chr11:106490902-106490903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150278381 | chr11:106490931-106490932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138797161 | chr11:106491027-106491028 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534499514 | chr11:106491076-106491077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34083594 | chr11:106491094-106491095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140524852 | chr11:106491132-106491133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546958837 | chr11:106491149-106491150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554218057 | chr11:106491152-106491153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs141036731 | chr11:106491168-106491169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191008192 | chr11:106491176-106491177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370081449 | chr11:106491187-106491188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536145640 | chr11:106491224-106491225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551205830 | chr11:106491244-106491245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs78072658 | chr11:106491283-106491284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs374303485 | chr11:106491290-106491291 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537163106 | chr11:106491324-106491325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs538542161 | chr11:106491362-106491363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs558332645 | chr11:106491415-106491416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:106489800-106490400 | Enhancers | Muscle Satellite Cultured Cells | -- |
2 | chr11:106489800-106491800 | Enhancers | Placenta Amnion | Placenta Amnion |
3 | chr11:106491800-106492600 | Weak transcription | Placenta Amnion | Placenta Amnion |
4 | chr11:106492600-106492800 | Enhancers | Placenta Amnion | Placenta Amnion |
5 | chr11:106492800-106493600 | Weak transcription | Placenta Amnion | Placenta Amnion |
6 | chr11:106496000-106496600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr11:106496400-106496600 | Enhancers | Placenta Amnion | Placenta Amnion |
8 | chr11:106496400-106496800 | Enhancers | Dnd41 | blood |
9 | chr11:106496400-106497200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr11:106502600-106503600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr11:106503400-106505600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr11:106511000-106512000 | ZNF genes & repeats | Dnd41 | blood |
13 | chr11:106511200-106511600 | ZNF genes & repeats | Aorta | Aorta |
14 | chr11:106511200-106511600 | ZNF genes & repeats | Pancreas | Pancrea |
15 | chr11:106511400-106511600 | ZNF genes & repeats | Left Ventricle | heart |
16 | chr11:106511600-106512600 | Weak transcription | Aorta | Aorta |
17 | chr11:106512800-106513200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
18 | chr11:106513000-106513200 | Enhancers | NHLF | lung |
19 | chr11:106513000-106513400 | Enhancers | Muscle Satellite Cultured Cells | -- |
20 | chr11:106513800-106514000 | Enhancers | NHLF | lung |
21 | chr11:106515200-106515600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |